Exact Mass: 444.158
Exact Mass Matches: 444.158
Found 500 metabolites which its exact mass value is equals to given mass value 444.158
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Tetracycline
Tetracycline is a broad spectrum polyketide antibiotic produced by the Streptomyces genus of Actinobacteria. It exerts a bacteriostatic effect on bacteria by binding reversible to the bacterial 30S ribosomal subunit and blocking incoming aminoacyl tRNA from binding to the ribosome acceptor site. It also binds to some extent to the bacterial 50S ribosomal subunit and may alter the cytoplasmic membrane causing intracellular components to leak from bacterial cells. A - Alimentary tract and metabolism > A01 - Stomatological preparations > A01A - Stomatological preparations > A01AB - Antiinfectives and antiseptics for local oral treatment D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06A - Antibiotics for topical use > D06AA - Tetracycline and derivatives J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01A - Tetracyclines > J01AA - Tetracyclines S - Sensory organs > S03 - Ophthalmological and otological preparations > S03A - Antiinfectives > S03AA - Antiinfectives S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics S - Sensory organs > S02 - Otologicals > S02A - Antiinfectives > S02AA - Antiinfectives D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors C784 - Protein Synthesis Inhibitor > C1595 - Tetracycline Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic (-)-Tetracycline. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=60-54-8 (retrieved 2024-09-27) (CAS RN: 60-54-8). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).
Doxycycline
Doxycycline is only found in individuals that have used or taken this drug. It is a synthetic tetracycline derivative with similar antimicrobial activity. Animal studies suggest that it may cause less tooth staining than other tetracyclines. It is used in some areas for the treatment of chloroquine-resistant falciparum malaria (malaria, falciparum). [PubChem]Doxycycline, like minocycline, is lipophilic and can pass through the lipid bilayer of bacteria. Doxycycline reversibly binds to the 30 S ribosomal subunits and possibly the 50S ribosomal subunit(s), blocking the binding of aminoacyl tRNA to the mRNA and inhibiting bacterial protein synthesis. Doxycycline prevents the normal function of the apicoplast of Plasmodium falciparum, a malaria causing organism. A - Alimentary tract and metabolism > A01 - Stomatological preparations > A01A - Stomatological preparations > A01AB - Antiinfectives and antiseptics for local oral treatment J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01A - Tetracyclines > J01AA - Tetracyclines D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C784 - Protein Synthesis Inhibitor > C1595 - Tetracycline Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Difenacoum
D006401 - Hematologic Agents > D000925 - Anticoagulants > D015110 - 4-Hydroxycoumarins D010575 - Pesticides > D012378 - Rodenticides D016573 - Agrochemicals
Fluticasone
R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03B - Other drugs for obstructive airway diseases, inhalants > R03BA - Glucocorticoids D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07A - Corticosteroids, plain > D07AC - Corticosteroids, potent (group iii) R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AD - Corticosteroids D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D000893 - Anti-Inflammatory Agents D018926 - Anti-Allergic Agents D003879 - Dermatologic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Desacetylmycothiol
(13S,14R)-1,8-Dihydroxy-13-O-acetyl-N-methylcanadine
Epitetracycline
Sanclomycine, also known as achromycin or 4 epitetracycline, belongs to the class of organic compounds known as tetracyclines. These are polyketides having an octahydrotetracene-2-carboxamide skeleton, substituted with many hydroxy and other groups. Based on a literature review very few articles have been published on Sanclomycine. This compound has been identified in human blood as reported by (PMID: 31557052 ). Epitetracycline is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Epitetracycline is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents Epitetracycline hydrochloride. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=23313-80-6 (retrieved 2024-10-30) (CAS RN: 23313-80-6). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).
Canagliflozin
fluticasone
Halometasone
Luprostiol
(2S)-1,1,1-Trifluoro-2-(4-pyrazol-1-ylphenyl)-3-[5-[[1-(trifluoromethyl)cyclopropyl]methyl]-1H-imidazol-2-yl]propan-2-ol
1,3-Diferuloylglycerol
1,3-diferuloylglycerol belongs to coumaric acids and derivatives class of compounds. Those are aromatic compounds containing Aromatic compounds containing a cinnamic acid moiety (or a derivative thereof) hydroxylated at the C2 (ortho-), C3 (meta-), or C4 (para-) carbon atom of the benzene ring. 1,3-diferuloylglycerol is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 1,3-diferuloylglycerol can be found in common wheat, which makes 1,3-diferuloylglycerol a potential biomarker for the consumption of this food product.
2-(4-Hydroxy-3-methoxybenzyl)-3-[(1,3-benzodioxole-5-yl)methyl]butane-1,4-diol 1,4-diacetate
(1S,2R,7aR,13aR)-2,3,13,13a-Tetrahydro-1,2,7a-trihydroxy-9,10-dimethoxy-3,3-dimethyl-1H-bis[1]benzopyrano[3,4-b:6,5-e]pyran-7(7aH)-one
Mortonin B
Isovolubilin
7-Hydroxy-5,4-dimethoxyflavone 8-C-rhamnoside
9beta-Acetoxy-8beta-(5-acetoxy-tiglinoyloxy)-lasiolaenin
(13S,14R)-1,8-Dihydroxy-13-O-acetyl-N-methylcanadine
5,7,8-Trihydroxy-3,6,4-trimethoxy-flavone 8-isovalerate
Raltegravir
J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AJ - Integrase inhibitors D004791 - Enzyme Inhibitors > D019429 - Integrase Inhibitors > D019428 - HIV Integrase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents C254 - Anti-Infective Agent > C281 - Antiviral Agent > C1660 - Anti-HIV Agent
5-Methoxypodophyllotoxin
relative retention time with respect to 9-anthracene Carboxylic Acid is 1.156 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.096 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.064 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.075
1,2-O-di-(trans-feruloyl)glycerol|1,2-O-diferuloylglycerol
alpha-D-Xylopyranosyl-(1鈥樏傗垎4)-beta-D-glucopyranosyl-(1鈥樏傗垎6)-D-glucose
rel-(1R,5S,6R,7S,8R)-Delta2,8-6-acetoxy-3,3,5-trimethoxy-4,5-methylenedioxy-4-oxo-8.1,7.5-neolignan
rel-(1R,4S,5R,7S,8R)-Delta2,8-4-acetoxy-3,3,5-trimethoxy-4,5-methylenedioxy-6-oxo-8.1,7.5-neolignan
3beta-acetoxy-8alpha-(5-acetoxyangeloyloxy)-eremanthin|3beta-acetoxy-8alpha-<5-acetoxyangeloyloxy>-eremanthin
demethyleugenol 4-O-beta-D-xylopyranosyl-(1?6)-O-beta-D-glucopyranoside
2-hydroxycinnamic alcohol 2-O-beta-D-apiofuranosyl-(1->6)-beta-D-glucopyranoside|cinnacasolide B
7-(2,3-Dihydroxy-3-methylbutoxy)-2-(1,3-benzodioxole-5-yl)-3,5-dimethoxy-4H-1-benzopyran-4-one
1-(2-hydroxy-6-methylphenyl)ethanone 2-O-(6-O-alpha-L-arabinofuranosyl)-beta-D-glucopyranoside|juniperoside IV
4-O-alpha-L-rhamnopyranosyl-(1?6)-beta-D-glucopyranosyl acetophenone
(Z)-1,3,6-trihydroxy-7-methoxy-2-(4-hydroxy-3-methylbut-2-enyl)-8-(3-hydroxy-3-methylbutyl)xanthone|schomburgxanthone
[4-(beta-D-glucopyranosyloxy)benzyl] 2,3-dihydroxy-3-methylbutanoate
4-allyl-2-hydroxyphenyl 1-O-beta-D-apiosyl-(1->6)-beta-D-glucopyranoside
3beta-acetoxy-8alpha-(4-acetoxyangeloyloxy)-eremanthin|3beta-acetoxy-8alpha-<4-acetoxyangeloyloxy>-eremanthin
(2S)-2-phenylpropionyl 6-O-beta-D-xylopyranisyl-beta-D-glucopyranoside
(8R,9S)-2-angeloyloxy-9-isovaleryloxy-dihydrooroselol
(2R,3S)-2-acetoxy-2,3-bis(3,4-dimethoxybenzyl)-gamma-butyrolactone
4-[2-(4-hydroxyphenyl)ethyl]benzofuran-2-carboxylic acid (2S,3R,4S,5S,6R)-tetrahydro-3,4,5-trihydroxy-6-(hydroxymethyl)-2H-pyran-2-yl ester|beta-D-glucopyranosyl 4-[2-(4-hydroxyphenyl)ethyl]benzofuran-2-carboxylate|tyrolobibenzyl A
Doxycycline
Tetracycline in which the 5beta-hydrogen is replaced by a hydroxy group, while the 6alpha-hydroxy group is replaced by hydrogen. A semi-synthetic tetracycline antibiotic, it is used to inhibit bacterial protein synthesis and treat non-gonococcal urethritis and cervicitis, exacerbations of bronchitis in patients with chronic obstructive pulmonary disease (COPD), and adult periodontitis. A - Alimentary tract and metabolism > A01 - Stomatological preparations > A01A - Stomatological preparations > A01AB - Antiinfectives and antiseptics for local oral treatment J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01A - Tetracyclines > J01AA - Tetracyclines D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C784 - Protein Synthesis Inhibitor > C1595 - Tetracycline Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE standard compound; EAWAG_UCHEM_ID 3678
Tetracycline
A - Alimentary tract and metabolism > A01 - Stomatological preparations > A01A - Stomatological preparations > A01AB - Antiinfectives and antiseptics for local oral treatment D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06A - Antibiotics for topical use > D06AA - Tetracycline and derivatives J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01A - Tetracyclines > J01AA - Tetracyclines S - Sensory organs > S03 - Ophthalmological and otological preparations > S03A - Antiinfectives > S03AA - Antiinfectives A broad-spectrum polyketide antibiotic produced by the Streptomyces genus of actinobacteria. S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics S - Sensory organs > S02 - Otologicals > S02A - Antiinfectives > S02AA - Antiinfectives D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors C784 - Protein Synthesis Inhibitor > C1595 - Tetracycline Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic CONFIDENCE Reference Standard (Level 1); HBM4EU - science and policy for a healthy future (https://www.hbm4eu.eu)
C20H28O11_Pentanedioic acid, 3-hydroxy-3-methyl-, [4-(beta-D-glucopyranosyloxy)phenyl]methyl methyl ester
C24H28O8_Furo[4,3,2-ij]pyrano[4,3:4,5]cyclohepta[1,2-f][2]benzopyran-1,5,9,13(2H,11H)-tetrone, 3a,5a,6,8,12,13a,13b,13c-octahydro-7-(hydroxymethyl)-2,5a,11,11,13a-pentamethyl
Halometasone
D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07A - Corticosteroids, plain > D07AC - Corticosteroids, potent (group iii) D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids C29629 - Combination Medication > C29639 - Topical Preparation > C29505 - Topical Corticosteroid D000893 - Anti-Inflammatory Agents D003879 - Dermatologic Agents
11-(hydroxymethyl)-2,6,6,14,19-pentamethyl-7,16,18-trioxapentacyclo[12.6.1.0²,¹².0⁵,¹⁰.0¹⁷,²¹]henicosa-5(10),11-diene-3,8,15,20-tetrone
Ala Cys Asp His
Ala Cys His Asp
Ala Asp Cys His
Ala Asp His Cys
Ala His Cys Asp
Ala His Asp Cys
Ala His Met Ser
Ala His Ser Met
Ala Met His Ser
Ala Met Ser His
Ala Ser His Met
Ala Ser Met His
Cys Ala Asp His
Cys Ala His Asp
Cys Asp Ala His
Cys Asp His Ala
Cys Glu Gly His
Cys Glu His Gly
Cys Glu Pro Pro
Cys Gly Glu His
Cys Gly His Glu
Cys His Ala Asp
Cys His Asp Ala
Cys His Glu Gly
Cys His Gly Glu
Cys His Ser Val
Cys His Val Ser
Cys Pro Glu Pro
Cys Pro Pro Glu
Cys Ser His Val
Cys Ser Val His
Cys Val His Ser
Cys Val Ser His
Asp Ala Cys His
Asp Ala His Cys
Asp Cys Ala His
Asp Cys His Ala
Asp His Ala Cys
Asp His Cys Ala
Asp His Ser Ser
Asp Ser His Ser
Asp Ser Ser His
Glu Cys Gly His
Glu Cys His Gly
Glu Cys Pro Pro
Glu Gly Cys His
Glu Gly His Cys
Glu His Cys Gly
Glu His Gly Cys
Glu Pro Cys Pro
Glu Pro Pro Cys
Gly Cys Glu His
Gly Cys His Glu
Gly Glu Cys His
Gly Glu His Cys
Gly His Cys Glu
Gly His Glu Cys
Gly His Met Thr
Gly His Thr Met
Gly Met His Thr
Gly Met Thr His
Gly Thr His Met
Gly Thr Met His
His Ala Cys Asp
His Ala Asp Cys
His Ala Met Ser
His Ala Ser Met
His Cys Ala Asp
His Cys Asp Ala
His Cys Glu Gly
His Cys Gly Glu
His Cys Ser Val
His Cys Val Ser
His Asp Ala Cys
His Asp Cys Ala
His Asp Ser Ser
His Glu Cys Gly
His Glu Gly Cys
His Gly Cys Glu
His Gly Glu Cys
His Gly Met Thr
His Gly Thr Met
His Met Ala Ser
His Met Gly Thr
His Met Ser Ala
His Met Thr Gly
His Ser Ala Met
His Ser Cys Val
His Ser Asp Ser
His Ser Met Ala
His Ser Ser Asp
His Ser Val Cys
His Thr Gly Met
His Thr Met Gly
His Val Cys Ser
His Val Ser Cys
Met Ala His Ser
Met Ala Ser His
Met Gly His Thr
Pro Cys Glu Pro
Pro Cys Pro Glu
Pro Glu Cys Pro
Pro Glu Pro Cys
Pro Pro Cys Glu
Pro Pro Glu Cys
Ser Asp His Ser
Ser Asp Ser His
Ser His Asp Ser
Ser His Ser Asp
Ser Ser Asp His
Ser Ser His Asp
(S)-Tamsulosin Hydrochloride
1,1-(6,7,9,10,17,18,20,21-Octahydrodibenzo[b,k][1,4,7,10,13,16]hexaoxacyclooctadecine-2,13-diyl)diethanone
diethyl 4-[2,6-bis(ethoxycarbonyl)pyridin-4-yl]pyridine-2,6-dicarboxylate
4-Defluoro-4-hydroxy Gefitinib
(3R,4R,5S,6R)-2-[3-[[5-(4-fluorophenyl)thiophen-2-yl]methyl]-4-methylphenyl]-6-(hydroxymethyl)oxane-3,4,5-triol
2-Propenoic acid, 3-(5-nitro-1-cyclohexen-1-yl)-, (1R)-4-(diphenylamino)-1-Methyl-4-oxo-2-butyn-1-yl ester, (2E)-
(4S,5S,6S)-6-[(1R)-2-[tert-butyl(diphenyl)silyl]oxy-1-hydroxyethyl]-5-hydroxy-2-oxo-1,3-dioxane-4-carbaldehyde
Canagliflozin
A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BK - Sodium-glucose co-transporter 2 (sglt2) inhibitors C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent D007004 - Hypoglycemic Agents > D000077203 - Sodium-Glucose Transporter 2 Inhibitors C471 - Enzyme Inhibitor > C98083 - SGLT2 Inhibitor
4-Methylphenyl 6-deoxy-2-O-(phenylmethyl)-1-thio-beta-L-galactopyranoside 3,4-diacetate
4-METHOXYPHENYL 3,4-O-ISOPROPYLIDENE-6-O-(4-METHYLBENZOYL)-BETA-D-GALACTOPYRANOSIDE
Tamsulosin hydrochloride
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D000089162 - Genitourinary Agents > D064804 - Urological Agents Tamsulosin hydrochloride ((R)-(-)-YM12617) is an inhibitor of α1-adrenergic receptor. Tamsulosin hydrochloride is used for the research of prostatic hyperplasia. Tamsulosin hydrochloride attenuates abdominal aortic aneurysm growth in animal models[1].
3-[2-[(E)-[1-[2-(4-methylanilino)-2-oxoethyl]-2,5-dioxoimidazolidin-4-ylidene]methyl]pyrrol-1-yl]benzoic acid
Tetracycline zwitterion
A zwitterion obtained by transfer of a proton from the 2-hydroxy group to the 1-amino group of tetracycline. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).
[9-(2-Carboxy-5-isothiocyanatophenyl)-6-(dimethylamino)xanthen-3-ylidene]-dimethylazanium
4-acetamido-N-[4-[2,5-dimethyl-1-(phenylmethyl)-3-pyrrolyl]-2-thiazolyl]benzamide
3-[(4Z)-5-oxo-3-phenyl-4-[(4-phenylphenyl)methylidene]pyrazol-1-yl]benzoic acid
N-[3-chloro-2-(1-piperidinyl)phenyl]-4-(4-morpholinyl)-3-nitrobenzamide
3-[2-(2-furanylmethylamino)-2-oxoethoxy]-N-(2-methoxy-5-methylphenyl)-2-naphthalenecarboxamide
4-[(4-Acetyl-2-methoxyphenyl)methoxy]-3-methoxybenzoic acid [1-(carbamoylamino)-1-oxopropan-2-yl] ester
3-Benzyl-2-(benzylimino)-5-(3,4-dimethoxybenzylidene)-1,3-thiazolidin-4-one
Alpha-D-Xylopyranosyl-(1->3)-Alpha-D-Xylopyranosyl-(1->3)-Beta-D-Glucopyranose
4-(dimethylamino)-6,10,12a-trihydroxy-6-methyl-1,3,11,12-tetraoxo-4a,5,5a,11a-tetrahydro-4H-tetracene-2-carboxamide
N-(1,5-dimethyl-3-oxo-2-phenyl-4-pyrazolyl)-1-(1H-imidazol-5-ylsulfonyl)-3-piperidinecarboxamide
N-[(2R,3S,6S)-6-[2-[(4-fluorophenyl)sulfonylamino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-4-oxanecarboxamide
4-(Dimethylamino)-5,10,12a-trihydroxy-6-methyl-1,3,11,12-tetraoxo-4,4a,5,5a,6,11a-hexahydrotetracene-2-carboxamide
N-[(2S,3R,6S)-6-[2-[(4-fluorophenyl)sulfonylamino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-4-oxanecarboxamide
N-[(2S,3R,6R)-6-[2-[(4-fluorophenyl)sulfonylamino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-4-oxanecarboxamide
N-[(2S,3S,6S)-6-[2-[(4-fluorophenyl)sulfonylamino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-4-oxanecarboxamide
N-[2-[(2S,5S,6S)-5-[[(2-fluorophenyl)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-1,3-benzodioxole-5-carboxamide
N-[2-[(2S,5S,6R)-5-[[(2-fluorophenyl)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-1,3-benzodioxole-5-carboxamide
N-[2-[(2S,5R,6R)-5-[[(2-fluorophenyl)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-1,3-benzodioxole-5-carboxamide
2-[(3S,6aR,8R,10aR)-1-[(3,4-dichlorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-propylacetamide
[(3aR,4R,9bR)-8-[2-(2-fluorophenyl)ethynyl]-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-(4-fluorophenyl)methanone
[(3aS,4S,9bS)-8-[2-(2-fluorophenyl)ethynyl]-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-(4-fluorophenyl)methanone
3-[2-[(E)-[1-[2-(2-methylanilino)-2-oxoethyl]-2,5-dioxoimidazolidin-4-ylidene]methyl]pyrrol-1-yl]benzoic acid
N-[(2R,3S,6R)-6-[2-[(4-fluorophenyl)sulfonylamino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-4-oxanecarboxamide
N-[(2R,3R,6R)-6-[2-[(4-fluorophenyl)sulfonylamino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-4-oxanecarboxamide
N-[(2S,3S,6R)-6-[2-[(4-fluorophenyl)sulfonylamino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-4-oxanecarboxamide
N-[(2R,3R,6S)-6-[2-[(4-fluorophenyl)sulfonylamino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-4-oxanecarboxamide
N-[2-[(2S,5R,6S)-5-[[(2-fluorophenyl)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-1,3-benzodioxole-5-carboxamide
N-[2-[(2R,5S,6R)-5-[[(2-fluorophenyl)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-1,3-benzodioxole-5-carboxamide
N-[2-[(2R,5R,6R)-5-[[(2-fluorophenyl)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-1,3-benzodioxole-5-carboxamide
N-[2-[(2R,5R,6S)-5-[[(2-fluorophenyl)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-1,3-benzodioxole-5-carboxamide
N-[2-[(2R,5S,6S)-5-[[(2-fluorophenyl)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-1,3-benzodioxole-5-carboxamide
[(3aR,4S,9bR)-8-[2-(2-fluorophenyl)ethynyl]-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-(4-fluorophenyl)methanone
4-(2-carboxyethyl)-7a-methyl-1-oxo-octahydro-1H-indene-5-carboxylic acid glucuronide
D-mannopyranosyl-(1->5)-D-arabinofuranosyl-(1->2)-D-arabinofuranose
7-[[2-(2,5-Dioxo-4-phenylimidazolidin-4-yl)phenyl]methyl]-1,3-dimethylpurine-2,6-dione
(4R,4aR,5R,5aR,6S,12aR)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide
1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside
Difenacoum
D006401 - Hematologic Agents > D000925 - Anticoagulants > D015110 - 4-Hydroxycoumarins D010575 - Pesticides > D012378 - Rodenticides D016573 - Agrochemicals
(4s,4ar,5s,5ar,6r,12as)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboximidic acid
8,8-dimethyl-10-[(2-methylbutanoyl)oxy]-2-oxo-9h,10h-pyrano[2,3-h]chromen-9-yl 2,3-dimethyloxirane-2-carboxylate
5-hydroxy-3-(4-methoxyphenyl)-7-{[(1r,2r,3s,4r,5r)-2,3,4-trihydroxy-5-(hydroxymethyl)cyclohexyl]oxy}chromen-4-one
5-hydroxy-3,4,19-trimethoxy-9,10-dimethyl-15,17-dioxatetracyclo[10.7.0.0²,⁷.0¹⁴,¹⁸]nonadeca-1(12),2,4,6,13,18-hexaen-11-yl acetate
8-(acetyloxy)-6-methyl-3,9-dimethylidene-2-oxo-3ah,4h,6ah,7h,8h,9ah,9bh-azuleno[4,5-b]furan-4-yl 4-(acetyloxy)-2-methylbut-2-enoate
(1r,4r,5r,6r,7r,8r,11r,13s,16s,17s,18s,19r)-4,5,6,7,8,16,17-heptahydroxy-6-(hydroxymethyl)-14,18-dimethyl-3,10-dioxapentacyclo[9.8.0.0¹,⁷.0⁴,¹⁹.0¹³,¹⁸]nonadec-14-en-9-one
1,3-dimethoxy-7-(7-methoxy-2h-1,3-benzodioxol-5-yl)-6-methyl-8-oxo-5-(prop-2-en-1-yl)bicyclo[3.2.1]oct-3-en-2-yl acetate
3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 4-[2-(4-hydroxyphenyl)ethyl]-1-benzofuran-2-carboxylate
(2r,3r,4s,5s,6r)-2-{[(2e)-3-(4-hydroxyphenyl)prop-2-en-1-yl]oxy}-6-({[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxane-3,4,5-triol
methyl 5-ethenyl-4-(4-methoxy-4-oxobut-1-en-1-yl)-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6-dihydro-4h-pyran-3-carboxylate
(2r,4r,6r,10s,12r,13r)-13-(acetyloxy)-4,15-dimethyl-8-oxo-12-(prop-1-en-2-yl)-3,7,17-trioxatetracyclo[12.2.1.1⁶,⁹.0²,⁴]octadeca-1(16),9(18),14-trien-10-yl acetate
(9r,13r)-4,5,6,16,17,18-hexamethoxy-11-oxatetracyclo[13.4.0.0²,⁷.0⁹,¹³]nonadeca-1(15),2(7),3,5,16,18-hexaen-10-one
1-(4-{[(2s,3r,4s,5r,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}phenyl)ethanone
3-[4-(1h-indol-3-yl)-2,3,5,6-tetramethoxyphenyl]-1h-indol-5-ol
(2r)-1-[(1s,2s)-2-[(s)-(acetyloxy)[(2r)-6-oxo-2,3-dihydropyran-2-yl]methyl]cyclopropyl]-1-oxopropan-2-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate
1-(4-{[4,5-dihydroxy-6-(hydroxymethyl)-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl]oxy}phenyl)ethanone
(3r,6r,7s)-7-(acetyloxy)-7-methyl-8-oxo-3-(prop-1-en-1-yl)-3,4,5,6-tetrahydro-1h-2-benzopyran-6-yl 2-hydroxy-4-methoxy-6-methylbenzoate
5,7-dihydroxy-2,2,6-trimethyl-8-{[2,4,6-trihydroxy-3-methyl-5-(2-methylpropanoyl)phenyl]methyl}-3h-1-benzopyran-4-one
4-(acetyloxy)-2-hydroxy-2,6,10,10-tetramethyl-12-oxo-11,13-dioxatricyclo[5.4.2.0¹,⁶]tridec-8-en-5-yl benzoate
3-[3-hydroxy-2-(2-hydroxypropan-2-yl)-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydro-1-benzofuran-5-yl]propanoic acid
16-(2-hydroxy-5-oxo-2h-furan-3-yl)-6,6,11,15-tetramethyl-7,17-dioxatetracyclo[13.2.1.0¹,¹².0⁵,¹¹]octadec-9-ene-3,8,18-trione
6-[(acetyloxy)methyl]-9a-(hydroxymethyl)-6-methyl-3-oxo-1h,4h,5h,5ah,7h,8h,9h-naphtho[1,2-c]furan-5-yl 4-hydroxybenzoate
1-(3-{[3-acetyl-2,4,6-trihydroxy-5-(3-methylbut-2-en-1-yl)phenyl]methyl}-2,6-dihydroxy-4-methoxy-5-methylphenyl)ethanone
(2s)-1-hydroxy-3-{[(2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}propan-2-yl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate
(3s,4s)-3-(hydroxymethyl)-5,6,7-trimethoxy-4-(3,4,5-trimethoxyphenyl)-3,4-dihydronaphthalene-2-carbaldehyde
11144737
{"Ingredient_id": "HBIN000288","Ingredient_name": "11144737","Alias": "NA","Ingredient_formula": "C20H28O11","Ingredient_Smile": "COC(=O)CC=CC1C(C(OC=C1C(=O)OC)OC2C(C(C(C(O2)CO)O)O)O)C=C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "636","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
4'-hydroxyacetophenone,8ci; o-[alpha-l-rhamnopyranosyl-(1→2)-beta-d-glucopyranoside]
{"Ingredient_id": "HBIN010504","Ingredient_name": "4'-hydroxyacetophenone,8ci; o-[alpha-l-rhamnopyranosyl-(1\u21922)-beta-d-glucopyranoside]","Alias": "NA","Ingredient_formula": "C20H28O11","Ingredient_Smile": "NA","Ingredient_weight": "0","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7826","PubChem_id": "NA","DrugBank_id": "NA"}